Litcius/Paper detail

Effects of bee venom and dopamine-loaded nanoparticles on reserpine-induced Parkinson’s disease rat model

Omar A. Ahmed‐Farid, Mohamed Taha, Rofanda M. Bakeer, Omyma K. Radwan, Hassan A. M. Hendawy, Ayman S. Soliman, Einas Yousef

2021Scientific Reports25 citationsDOIOpen Access PDF

Abstract

Parkinson's disease (PD) is a progressive chronic neurodegenerative condition characterized by the loss of dopaminergic neurons within the substantia nigra. Current PD therapeutic strategies are mainly symptomatic and can lead to motor complications overtime. As a result, alternative medicine may provide an effective adjuvant treatment for PD as an addition to or as a replacement of the conventional therapies. The aim of this work was to evaluate the effects of Bee Venom (BV) and dopamine (DA)-loaded nanoparticles in a reserpine-induced animal model of PD. After inducing PD with reserpine injection, different groups of male rats were treated with L-Dopa, BV, DA-nanoparticles. Our findings showed that BV and DA-nanoparticles administration restored monoamines, balanced glutamate/GABA levels, halted DNA fragmentation, decreased pro-inflammatory mediators (IL-1β and TNF-α), and elevated anti-inflammatory mediators (PON1) and neurotropic factor (BDNF) levels in comparison with conventional therapy of PD. Furthermore, in a reserpine-induced PD rat model, the ameliorative effects of BV were significantly superior to that of DA-nanoparticles. These findings imply that BV and DA-nanoparticles could be useful as adjuvant treatments for PD.

Topics & Concepts

ReserpineDopamineParkinson's diseaseDopaminergicPharmacologySubstantia nigraMedicineMicrodialysisNeurotransmitterMethamphetamineInternal medicineChemistryEndocrinologyDiseaseCentral nervous systemHealthcare and Venom ResearchBee Products Chemical AnalysisInsect and Pesticide Research
Effects of bee venom and dopamine-loaded nanoparticles on reserpine-induced Parkinson’s disease rat model | Litcius